SCHEMBL653499

SCHEMBL653499

CCNCCCCCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19555074 1.00 CYP1A2 (0.60)
SCHEMBL655394 1.00 CYP1A2 (0.60)
SCHEMBL11757870 1.00 CYP1A2 (0.60)
SCHEMBL8501062 1.00 CYP1A2 (0.60)
SCHEMBL7805280 1.00 CYP1A2 (0.60)
SCHEMBL23093989 1.00 CYP1A2 (0.60)
SCHEMBL18235893 1.00 CYP1A2 (0.60)
SCHEMBL21799840 1.00 CYP1A2 (0.60)
SCHEMBL20968104 1.00 CYP1A2 (0.60)
SCHEMBL8498848 1.00 CYP1A2 (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120005137-A Microcapsule closed type polybasic isocyanate, medium, grating and preparation method and equipment 珠海莫界科技有限公司 2025-05-16 CN claimed
CN-118085273-A Polyamide resin and preparation method and application thereof 华峰集团有限公司 2024-05-28 CN claimed
CN-114507164-B Gemini surfactant, preparation method, composition and application thereof 中国石油天然气股份有限公司 2023-10-24 CN claimed
CN-116410101-A Asymmetric Gemini surfactant, preparation method and application thereof 中国石油天然气股份有限公司 2023-07-11 CN claimed
CN-114507164-A Gemini surfactant, preparation method, composition and application thereof 中国石油天然气股份有限公司 2022-05-17 CN claimed
US-20070078146-A1 Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma PHARMACIA CORPORATION 2007-04-05 US claimed
EP-1144403-B1 SUBSTITUTED PYRAZOLES AS P38 KINASE INHIBITORS SEARLE LLC (US) 2004-10-06 EP claimed
US-6617324-B1 Phenyl, cyclohexyl and pyridinyl or pyrimidinyl-substituted G. D. SEARLE & COMPANY 2003-09-09 US claimed
US-6514977-B1 For treating p38 kinase mediated disorders G.D. SEARLE & COMPANY 2003-02-04 US claimed
US-6423713-B1 Substituted pyrazoles as p38 kinase inhibitors G. D. SEARLE & COMPANY 2002-07-23 US claimed
EP-1144403-A1 SUBSTITUED PYRAZOLES AS P38 KINASE INHIBITORS G.D. SEARLE & CO. (US) 2001-10-17 EP claimed
WO-2000031063-A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS G.D. SEARLE & CO. (US) 2000-06-02 WO claimed
CN-120005137-A Microcapsule closed type polybasic isocyanate, medium, grating and preparation method and equipment 珠海莫界科技有限公司 2025-05-16 CN disclosed
CN-116410101-B Asymmetric Gemini surfactant, preparation method and application thereof 中国石油天然气股份有限公司 2025-02-28 CN disclosed
EP-3623398-B1 RESIN COMPOSITION COMPRISING A MODIFIED BLOCK COPOLYMER AND METHOD FOR PRODUCING MODIFIED BLOCK COPOLYMER ASAHI CHEMICAL IND (JP) 2024-08-28 EP disclosed
CN-118085273-A Polyamide resin and preparation method and application thereof 华峰集团有限公司 2024-05-28 CN disclosed
US-4918107-A HYDROXYPHENYLACETYL-L-ASPARAGINYL COMPOUNDS TSUMURA & CO. (JP) 1990-04-17 US disclosed
EP-0108986-A1 N-substituted flavone-8-carboxamides Hokuriku Pharmaceutical Co.,Ltd (JP) 1984-05-23 EP disclosed
US-4098846-A IMPACT STRENGTH GENERAL ELECTRIC COMPANY (US) 1978-07-04 US disclosed
US-4054553-A MANGANESE COMPLEX CATALYST GENERAL ELECTRIC COMPANY (US) 1977-10-18 US disclosed